Daiichi Sankyo’s Stock Plunge Signals Urgent Need for Strategic Shift in Pharma Sector
Daiichi Sankyo’s stock price has plummeted by 5.42% on the Tokyo Stock Exchange, sparking concerns that the company’s focus on traditional pharmaceuticals may be its downfall in a rapidly changing market.
2 minutes to read